<DOC>
	<DOCNO>NCT01526122</DOCNO>
	<brief_summary>The purpose study compare characteristic safety oral administration G0041 ( 75/100mg ) 2 tablet Clopidogrel 75mg 2 tablet &amp; Aspirin 100mg 2 capsule coadministration healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetics &amp; Safety Study Clopidogrel 75mg Aspirin 100mg Coadministration</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>healthy male volunteer age 20 50 year old weight 55kg within range ±20 % IBW neither congenital/chronic disease pathological symptoms/findings result medical examination doctor determine suitable subject within 3 week ago administration Hypersensitivitiy ( history hypersensitivity ) aspirin clopidogrel Active Liver Diseases exceed 1.5 time normal range AST , ALT , total bilirubin Exceed normal range PT , aPTT , BT &amp; platelet count 150,000/㎣ exceed 350,000/㎣ Creatinine clearance &lt; 80 mL/min Gastrointestinal disease surgery affect absorption drug Congenital galactose intolerance , lactase deficiency glucosegalactose malabsorption Excessive drinking ( exceed 21units/week ) Smoking 10 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>coadministration</keyword>
</DOC>